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Renal graft survival has improved over the past years, mainly owing to better immunosuppression. Vascular thrombosis, though
rare, therefore accounts for up to one third of early graft loss. We assess current literature on transplantation, identify thrombosis
risk factors, and discuss means of avoiding thrombotic events and saving thrombosed grafts. The incidence of arterial thrombosis
was reported to 0.2–7.5% and venous thrombosis 0.1–8.2%, with the highest incidence among children and infants, and the lowest
in living donor reports. The most signiﬁcant risk factors for developing thrombosis were donor-age below 6 or above 60 years, or
recipient-age below 5-6 years, per- or postoperative hemodynamic instability, peritoneal dialysis, diabetic nephropathy, a history
of thrombosis, deceased donor, or >24 hours cold ischemia. Multiple arteries were not a risk factor, and a right kidney graft was
most often reported not to be. Given the thrombosed kidney graft is diagnosed in time, salvage is possible by urgent reoperation
and thrombectomy. Despite meticulous attentions to reduce thrombotic risk factors, thrombosis cannot be entirely prevented and
meanstoanearlydetectionofthiscomplicationisdesirableinordertosavethekidneysthroughpromptreoperation.Microdialysis
may be a new tool for this.
1.Background
In 1905, the ﬁrst paper on kidney transplantation was pub-
lished [1]. The French surgeon Alexis Carrel had, in the
preceding years, developed techniques for vascular suture
and anastomoses. In 1902, he transplanted a kidney from a
small-sizedog into itsneck withtherenalarteryjoined tothe
carotid artery and the vein to the external jugular vein. After
three days, he noted a slightly greater blood ﬂow than in the
normal kidney and a urine production that was ﬁve times
greater in the transplanted kidney. The animal died from an
infection within few days. In 1912, Alexis Carrel received the
Nobel Prize for his work.
Fifty years after the pioneering experiments, the ﬁrst suc-
cessful human renal transplantation was carried out in
Boston by Dr. Joseph Murray in 1954 [2]. The donor was
the patient’s identical twin brother. Preceding the operation,
monozygosity was conﬁrmed by the successful exchange
of a full thickness skin graft between the brothers. The
transplanted kidney functioned for eight years until cardiac
deathofthepatient.Inthesucceedingdecades,atremendous
development has been taking place, with an increasing
understanding of immunological aspects of transplantation
and the opportunity for pharmacological immunosup-
pression, which was revolutionized after introduction of
cyclosporine in the late seventies. In 1990, Joseph E. Murray
and E. Donnall Thomas received the Nobel Prize for their
discoveries concerning organ and cell transplantation in the
treatment of human disease.
In 2012, kidney transplantation remains the best treat-
mentofend-stagerenaldisease(ESRD)resultinginimproved
health and quality of life [3] as well as decreased health2 Journal of Transplantation
expenses compared to sustained dialysis [4]. Renal graft
survival has improved over the past years, mainly owing
to better immunosuppression. As a consequence, although
vascular thrombosis is a rare complication, it has become a
major cause of early graft loss, accounting for up to one third
of graft loss within one month [5] and up to 45–47% within
two to three months [6]. In the pediatric NAPRTCS (North
American Pediatric Renal Transplant Coorporative Study)
cohort from 1996–2001, thrombosis was the most common
cause of early graft loss [7].
2. Incidenceof Vascular Thrombosis
Thesurgicaltechniquehasonlyseenminorchangessincethe
ﬁrst renal transplantations were accomplished. Usually the
kidney is placed extraperitoneally in the iliac fossa with end-
to-side anastomoses to the external iliac artery and vein. In
small children and infants, however, this approach is often
associated with an increased risk of thrombosis [8]. To avoid
this, the kidney graft is anastomosed end-to-side to the distal
abdominal aorta and caval vein.
Vascular thrombosis is a devastating complication
because it most often leads to renal graft loss. Overall, the
incidence of arterial thrombosis is reported to be 0.2–7.5%
and venous thrombosis to be 0.1–8.2% as seen from Tables 1
and 2 with the highest incidence among children and infants
and lowest in reports with only living donors. The incidence
range is wide and many studies are not comparable due to
diﬀerences in composition of recipients and donors, such as
diﬀerent percentage of deceased donors.
In one of the studies with the lowest number of throm-
bosis [17], only living donors were used and furthermore
the recipients were selected with an exclusion of diabetic
patients. The pediatric patients from this cohort were later
examined [35, 37] with no thromboses reported. This is
unusual but could partly be due to selection of low risk
donors between 21–60 years of age. In addition, there were
no transplanted children below 5 years of age. In contrast,
a subanalysis of NAPRTCS [26] revealed thrombosis-caused
graft loss in 1.7% of all children receiving kidneys from
a living donor. In the children less than 6 years of age,
the incidence was 6.7%. These numbers are probably more
reliable because NAPRTCS includes children of all ages and
prospectively collected data on all pediatric patients in 73
centers [7].
Unfortunately, only few of the study data available are
prospectively collected [7, 11, 19, 26, 28, 29, 31, 34], while
most of them are retrospective. Five studies were named
“consecutive case series” without thorough description of
data collection [6, 9, 15, 17, 35]. This increases risk of
bias and missing data. However, as thrombosis is an early
complication that ultimately leads to graft loss in most
cases, it is unlikely that it will go unnoticed. The question
is of course, whether the cause of graft failure is correctly
recorded in the medical chart. Three case-control studies
are included in Table 1. Two of these included all cases
from prospectively collected multicenter studies; Penny et al.
[5] found 134 index cases of thrombosis in the Australian
and New Zealand database, they selected an institutional
control—which was the transplantation preceding the index
case in the same institution and a donor graft control, the
recipient of the kidney contralateral of the index case. Ojo
et al. [13] identiﬁed 751 cases of thrombosis within the ﬁrst
30 days in the prospectively collected United Network for
Organ Sharing (UNOS) database, only 8 (1.1%) had to be
excluded due to missing data. The cases were individually
matched with two controls from the same year and the same
transplantation center. The third case-control study is from a
single center with the contralateral kidney as the only control
[25]; the thrombosis case was solely included when the other
kidney was transplanted in the same center thus leading to
many exclusions and only 24 of 42 (57%) cases available for
analysis.
3. Donors Risk Factors for the Development of
VascularThrombosis
Historically, renal grafts with multiple arteries have been
associated with an increased risk of thrombosis [38]; how-
ever, this does not seem to be the case in the modern
transplantera[6,12,15,17,18,21,22,27,30,32]wher eev en
a kidney with six arteries was successfully implanted [39].
Only one retrospective study from Iran reports signiﬁcantly
more surgical complications after multiple vessel kidney
transplantation compared with recipients of single-artery
graft [24]. In their statistical analyzes, they have analyzed
hemorrhage, artery stenosis, renal artery thrombosis, and
renal vein thrombosis all together, with the latter two being
least frequent. It has previously been reported that multiple
arteries is an independent risk factor for hemorrhage [17],
ultimately leading to graft nephrectomy in 22% of the cases.
This factor may carry weight in the ﬁrst mentioned analysis,
as they had a higher incidence of hemorrhage: 6.1% [24]
compared to 1.9% in the latter [17]. No separate analysis for
thromboses alone was provided from the Iranian center.
Surplus renal arteries are found in 10–20% of the
population. In order to succeed in overcoming the technical
challenges, it requires an experienced surgeon with an in-
depth knowledge of possible variations in renal arterial
anatomy and of microsurgical techniques for vascular recon-
struction [39]. The arteries can either be anastomosed
individually, in a Carrel patch (deceased donors), or they
can be converted to a single artery, which will increase bench
surgery time but decrease operative time for anastomosis.
There is no general consensus about whether a right
renal graft has increased thrombosis risk compared to the
left. A few centers, with both high and low thrombosis
incidence, ﬁnd no association [15, 17, 32], while others
r e p o r tad r a m a t i cd i ﬀerence [6, 14, 25]. A recent publication
from Spain [25] identiﬁed all kidney grafts thrombosed
within 30 days after transplantation. The transplantation
outcome of the contralateral kidney from the same donor
wasalsoidentiﬁedandservedascontrol.Twenty-fourkidney
pairs were analyzed and revealed no signiﬁcant diﬀerences in
recipients’characteristics,butahugediﬀerenceingraftsides,
with 21 thrombosed right kidney graft (87.5%) versus threeJournal of Transplantation 3
Table 1: RAT: Renal artery thrombosis, RVT: renal vein thrombosis, : mean, ∗: % deceased, ∗∗: see text, c.s.: case series, c.r.: chart review,
N/A: not available.
Author Nationality Year N Recipient age Donor∗ RAT + RVT RAT RVT Study design
Jordan [9] Canada, Toronto 1970–1980 341 13–67 84 4.4% (15) 3.5% (12) 0.9% (3) Consecutive c.s.
Penny [5] Australia, ANZDATA 1980–1992 6153 N/A N/A 2.2% (134) 1.1% (70) 1.0% (64) Case-control∗∗
Murphy [10] Ireland, Belfast 1989–1992 202 adults N/A 4.5% (9) 1.0% (2) 3.5% (7) Retrospective
Stechman [11] UK, Oxford 1997–1992 401 27–75 78 1.0% (4) 0.75% (3) 0.25% (1) Prospective
Benedetti [12] USA, Minnesota 1985–1993 998 16–74 51 1.4% (14) 0.4% (4) 1.0% (10) Retrospective
Bakir [6] Holland, Groningen 1986–1994 558 14–71 100 6.1% (34) 2.0% (11) 3.4% (19) Consecutive c.s.
Ojo [13] USA, UNOS 1990–1996 84513 >18 N/A 0.9% (751) N/A N/A Case-control∗∗
Perez [14] Spain, A Coru˜ na 1988–1997 827 44 100 5.7% (47) 2.3% (19) 3.4% (28) Retrospective
Englesbe [15] USA, Michigan 1993–1997 714 all 43 1.82% (13) 0.8% (6) 1.0% (7) Consecutive c.s.
Samhan [16] Kuwait, Hawaly 1993–1998 151 all 24 3.3% (5) 2.6% (4) 0.7% (1) N/A
Osman [17] Egypt, Mansoura 1976–1999 1200 5–62 0 0.5% (12) 0.4% (5) 0.1% (1) Consecutive c.s.
Mazzucchi [18] Brazil, Sao Paulo 1995–1999 356 18–70 64 1.4% (5) 0.3% (1) 1.12% (4) Retrospective c.r.
Parada [19] Portugal, Coimbra 1980–2001 1000 41 98 0.9% (9) 0.6% (6) 0.3% (3) Prospective
Orlic [20] Croatia, Rijka 1971–2002 725 N/A 53 1.1% (8) 0.6% (4) 0.6% (4) N/A
Hern´ andez [21] Spain, Tenerife 1996–2004 870 18–76 100 4.8% (42) 3% (26) 1.8% (16) Retrospective c.r.
Sanni [22] UK, Newcastle 1990–2005 1308 N/A 93 2.8% (36) N/A N/A Retrospective
Dimitroulis [23] Greece, Athens 1980–2005 1367 N/A 44 2.3% (31) 2% (27) 0.3% (7) Consecutive
Salehipour [24] Iran, Shiraz 1988–2006 1500 4–70 20 1.1% (16) 0.6% (9) 0.5% (7) Retrospective c.r.
Am´ ezquita [25] Spain, Madrid 1990–2006 772 N/A 100 5.5% (42) N/A N/A Case-control∗∗
Table 2: Pediatric patients: RAT: Renal artery thrombosis, RVT: Renal vein thrombosis, ∗: % deceased, mc: multicenter, c.s.: case series,
N/A: not available.
Author Nationality Year N Recipient age Donor∗ RAT + RVT RAT RVT Study design
Harmon [26] USA, NAPRTCS 1987–1989 1045 0–17 54 2.6% (27) N/A N/A Prospective, mc.
van Lieburg [27] Holland, Nijmegen 1977–1990 100 children 93 12% (12) 4% (4) 7% (7) Retrospective
McEnery [28] USA; NAPRTCS 1987–1992 2193 0–17 55 3.2% (71) N/A N/A Prospective, mc.
Johnson [29] UK, Ireland 1986–1995 1252 <18 100 4.0% (50) N/A N/A Prospective, mc.
Ismail [30] Poland, Warsaw 1984–1995 176 1–18 92 4.0% (7) 1.7% (3) 2.7% (4) Retrospective
Kamel [31] Ireland, Dublin 1986–1998 120 1–17 100 5% (6) 0.8% (1) 4.2% (5) Prospective
Adams [8] Germany, Heidelberg 1977–1998 61 1–6 77 13.1% (8) 4.9% (3) 8.2% (5) Retrospective
Nagra [32] UK, London 1987–2000 254 1–16 75 9.8% (25) N/A N/A Retrospective
McDonald [7] USA; NAPRTCS 1987–2001 7247 0–17 47 2.7% (199) N/A N/A Prospective, mc.
Mickelson [33] Canada, Vancouver 1984–2003 24 1–6 71 4.2% (1) 4.2% (1) N/A Retrospective
Kranz [34] Germany, Essen 1998–2003 66 children 74 0 0 0 Prospective
El-Husseini [35] Egypt, Mansoura 1976–2004 216 5–18 0 0 0 0 Consecutive c.s.
Garcia [36] Brazil, Porto Alegre 1989–2005 40 1–5 25 10% (4) 7.5% (3) 2.5% (1) N/A
left kidneys. This corresponds to the results from a center in
The Netherlands [6], where 85% of the thrombosed kidneys
were right versus 58% of the controls without thrombosis.
The right kidney has a short vein and long artery, which can
make it more diﬃcult to position. The artery can easily be
kinked and the vein is prone to compression by the kidney.
This is supported by a signiﬁcant association between right
kidney and technical surgical problems in a multivariate
analysis [6]. Like problems with multiple vessels can be
overcome; right kidneys may not compose such a substantial
risk factor, when operated by a meticulous surgeon.
The renal graft is often positioned in the contralateral
iliac fossa, but also the same side as the original position can
be used as there is no association between complications and
the side of graft placement [6, 12, 15, 17].
On average, around 35% of all renal transplantations are
carried out with a kidney from a living donor with large
variation from country to country. When using a living
donor, the anatomy is well known preoperatively and the
procedure is scheduled. This often leads to better results
and fewer thromboses [7], which is also evident from Tables
1 and 2. Many studies do not demonstrate an increased
risk of thrombosis after receiving a kidney from a deceased
donor compared to a living donor [12, 13, 15, 24, 30, 32].
This may be due to relatively small study populations with
ad i ﬀerent mix of donor compositions. However, in the4 Journal of Transplantation
NAPRTCS reports the overall thrombosis incidence has not
declined in spite of a higher fraction of living donors in
recentyears[7,26].Ontheotherhand,thequestionhasbeen
raised weather laparoscopic nephrectomy in fact comprises a
risk factor. A large register study demonstrated signiﬁcantly
more frequent delayed graft function and acute rejection in
children after laparoscopic compared to open living donor
nephrectomy [40, 41]. However, this has been questioned in
a recent publication from three large centers, where similar
results for open and laparoscopic procedure have been found
[42]. In both series, there have been a minimal number
of thromboses and hence no statistical conclusions can be
made.
A female donor doubles the risk of thrombosis in the
case-control study from the Australian and New Zealand
Dialysis and Transplant Registry [5], probably due to smaller
vessel size, as suggested by the authors. However, this has not
been conﬁrmed in other studies [6, 13, 15, 27, 32].
Although few studies ﬁnd no association between donor
age and thrombosis [6, 12, 17], convincing studies point to
the contrary [5, 7, 14, 15, 32]. There is no consensus on how
the age analyzes should be performed, which may explain
some of the dispute. In the former retrospective studies that
found no association, one is analyzed for donor age >45 or
<45 years [12], another used no donors from extreme age
groups [17], and the last one did not divide into smaller age
groups before analyzing and found no association within an
adult donor population [6]. When stratiﬁed into age groups,
a poorer outcome is found when the donors are very young
[7,14,32],especiallywhenlessthansixyearsofage[7,14]or
the recipient is a child. If the renal grafts are <7cm in length,
they are often transplanted en bloc into the recipient [43].
However, kidneys grow fast when transplanted into a larger
recipient [43], and it may thus be desirable to transplant
the kidneys individually whenever possible. Also donors >60
years increase the thrombosis risk [14], which might be
connected with more atherosclerotic vessels.
Warm ischemic time (WIT) has not been found to be a
risk factor for thrombosis development [6, 13, 15, 17, 21].
This should be interpreted with caution, as it is very likely
to be caused by similar low WIT for most kidneys. Cold
ischemic time (CIT) varies more, and this is also reﬂected
in the risk analyzes. Many studies state no increased risk with
increasing CIT [6, 12, 13, 15, 21, 25, 30], often these reports
have relatively low CIT at a mean of 20-21 hours [21, 25].
Other reports with fairly larger study populations state a
higher thrombosis incidence with longer CIT [5, 7, 14, 32],
especially when it exceeds 24 hours [7, 32]. This is based on
univariate analyzes and little information is provided on the
reasons for extended CIT, hence confounding events cannot
be ruled out (Table 3).
4. RecipientRisk Factorsfor Development of
VascularThrombosis
As previously mentioned, the placement of the renal graft
in small children may inﬂuence the thrombotic risk. In a
retrospectiveGermanstudy,childrenaged6yearsoryounger
Table 3: Factors associated with increased risk of thrombosis.
Increased risk of thrombosis
Donors Recipients
Donor age >60 Recipient age <5–6 or >50
Young donors <6 years Peritoneal dialysis
Cold ischemic time >24h Recipient diabetes mellitus
Renal vessel atherosclerosis Renal vessel atherosclerosis
Right kidney History of thrombosis
Technical surgical problems
Illiac graft anastomosis, age <6 years
Hemodynamic instability
No use of aspirin
Delayed graft function
had kidney grafts transplanted either retroperitoneally to the
iliac vessels in the fossa iliaca or extraperitoneally with end-
to-side anastomoses to the distal aorta and caval vein [8].
The procedure was switched from the former to the latter in
1990, and when there was an equal number in both groups
the outcomes were analyzed. Anastomoses to the iliac vessels
strongly increased the risk of thrombosis, which occurred in
25.8% of the patients versus 3.3% of the children operated
withaorticandcavalanastomoses.Incontrast,anotherstudy
found no association between placement of the graft and loss
due to thrombosis, but they included children up to 16 years
of age and gave no separate analysis for the youngest children
[32]. Although the aortic/caval approach is now accepted as
the best for the small children, it is still debated whether
trans- or extraperitoneal access is to be favored. Seemingly,
extraperitoneal placement provides similar graft outcome,
and it limits gastrointestinal complications considerably
[44], hence this approach is used in most centers.
Intra- and postoperative hemodynamic instability is
rarely mentioned in transplantation outcome reports, maybe
because the data are not always accessible. Nevertheless, this
may be an important contributor to thrombotic risk. In a
retrospectivereportfromTheNetherlands,itwasfoundtobe
an independent risk factor [6]. It was deﬁned as period(s) of
hypotension, mean arterial blood pressure ≤70mmHg, for
more than 10 minutes intraoperatively or during the ﬁrst 48
hours postoperatively. This was the case among 32.5% of the
patients who later suﬀered from acute vascular thrombosis,
while only 4.5% of the controls had hypotensive period(s).
33.3% (11/33) of hemodynamic instable patients developed
thrombosis and lost their graft. This has been described
previously in another study, where one of twelve arterial
thromboses was explained by intraoperative hypotension
with visibly poor perfusion to the kidney [9]. A pediatric
study suggests hemodynamic instability to be even more
important in children and ﬁnd the young child more prone
to nontechnical thrombosis because of a relatively low
cardiac output, particularly in relation to a much larger
kidney that leads to less eﬃcient renal perfusion [45], hence
an aggressive ﬂuid therapy and cardiovascular monitoring
are crucial.Journal of Transplantation 5
Duetotransplantationbeingarelativelyinfrequentoper-
ation in many centers, some reports only have few patients of
extreme ages and a diﬀerence was not always found [6, 12,
13, 17, 25]. In a NAPRTCS report with a substantial number
of very young recipients down to 0-1 years of age together
with older children, age was only approaching signiﬁcance as
apredictorofgraftthrombosis[7].Inotherpediatricreports,
the patients developing a thrombosed graft are younger [27],
usually below 5–6 years [26, 32]. Yet, excellent pediatric
outcomewithnothrombosesisseeninsomecenters[46,47],
even though a high proportion of the children have been
very young. In both reports, some of the success is attributed
to a very aggressive ﬂuid management, and they underscore
the critical importance of appropriate ﬂuid resuscitative
measures in small recipients of adult-sized kidneys [47]. A
minimum recipient weight of 5, preferable 10kg is suggested
p r i o rt oo p e r a t i o n[ 36]. The operative technique is based on
the weight and not the age of the child.
Also elderly recipients are more prone to graft throm-
bosis [48]. Nevertheless, it is becoming more common to
transplant patients at older ages and hence, in 2007 up
to 18.9% of transplantations in American centers were
performed in patients >65 years. When the patients were
appropriately selected, a short time graft survival similar
to that of other adults was noted [49]. This was also
the conclusion in another study, where they propose that
chronologicalagebarriersshouldbesubstitutedbybiological
limits [50].
In the preceding paragraph, it was concluded that donor
gender was of less importance. The same is the case for
recipient gender, with only one large case-control study
ﬁnding a 46% higher likelihood of thrombosis in women
[13], while several others report no association [6, 7, 15, 17,
24, 25, 32]. Overall, 54–74% of reported recipients are male,
in agreement with a higher prevalence of end-stage renal
disease (ESRD) in men [51].
The underlying disease that causes ESRD in the patient
also plays a role in the transplantation outcome. Of
signiﬁcance is diabetic nephropathy [6, 13, 15]w i t ha n
increased thrombotic risk. This might be because of diabetic
angiopathy, as also atherosclerosis of either the recipient or
donor vessels increases the risk [21, 22]. However, a Spanish
case-control study with rather few subjects in the analysis
foundno associationwithdiabetesmellitus[25]andanother
found no connection to any underlying disease [5]. Systemic
lupuserythematosusincreasesthethrombosisriskcompared
to hypertensive nephropathy [13]. This is most probable due
to the antiphospholipid antibody syndrome, which has been
pointed out earlier [52].
The progression of the renal disease and possible comor-
bidities determine when and how the patient should be
treated. There are three renal replacement options when
reaching ESRD: transplantation, hemodialysis (HD), and
peritoneal dialysis (PD). The choice, order, and duration of
treatment can have a substantial impact on transplantation
outcome. Preemptive transplantation, that is, when the new
kidney is transplanted before initiation of dialysis, while the
native kidneys still have a high urine production, is preferred
to avoid dialysis and associated especially cardiovascular
risks, but it has been found to be associated with increased
thrombosis risk compared to transplantation after initiation
of HD [7, 13]. Furthermore, a high native urine production
in combination with dialysis is a risk factor [27]. It is
speculated that these patients may be more diﬃcult to
keep in a relatively volume-expanded state in the intra-
and postoperatively. Preemptive transplantation is favored
whenever possible, as its superior long-term graft survival is
well established [53, 54]. However, more focus is warranted
on aggressive and well-monitored ﬂuid management of
patientsundergoingtransplantationandpreoperativestopof
medical treatment like diuretics and antihypertensive drugs
except for beta blockers.
Several studies with large patient cohorts ﬁnd substantial
more thrombotic graft loss among patients who have been
on PD prior to transplantation compared to HD [7, 10,
13, 55], while just a few retrospective studies state the
type of dialysis not to aﬀect the graft outcome [6, 14].
An acquired thrombophilic state may be involved, possibly
due to selective protein loss in the peritoneal ﬂuid, like in
nephrotic syndrome. Another contributing factor could be
selection of patients; they might have been switched from
HD to PD because of vascular access problems, which may
indicate atherosclerosis. At least this switch has been found
to increase risk more than PD in itself [13]. In a retrospective
study, thrombosis has been reported to comprise up to 41%
ofearlygraftfailureamongPDpatientsandonly30%among
HD patients [55]. Antithrombotic treatment of HD patients
during sessions or a more eﬃcient dialysis may contribute
as well. However, these observations should be carefully
interpreted, as the data for the cause of early graft loss were
available from only one third of the cases in this study.
Inherited or acquired forms of thrombophilia increase
the risk of thrombosis in general and hence also in a newly
received renal graft and anticoagulation may be a sound
consideration. Screening for thrombophilia has shown to
decrease the number of thrombotic events [34, 56]. This
c a nb ed o n ei nd i ﬀerent ways: one study has screened blood
samples of all patients prior to transplantation [34], while
another screened the patients by registration of history of
prior thrombosis including deep venous thrombosis, mul-
tiple miscarriages, or family history of thrombosis among
others [56]. Subsequently, these patients had thrombophilia
conﬁrmedbylaboratorytests.Twopatientsnotinitiallyiden-
tiﬁed by this method developed thrombotic complications
and had a hypercoagulable disorder documented afterward.
Transplantation of recipients with nephrotic syndrome is a
risk factor for thrombosis, particularly in small recipients
where nephrectomy prior to transplantation should be
considered.
Some studies are too underpowered to detect an eﬀect of
anticoagulation among unselected recipients. For instance,
heparinisusedprophylacticincaseofvagueriskfactors[17],
but it has also been shown not to aﬀect the outcome [32]. In
thelatterstudy,only254patientswereincluded,eventhough
their power calculation required at least 1,500 patients in
each arm. Furthermore, the patients were not randomized
to heparin or not, but by 1994 heparin was implemented as
routine treatment, and the patients were divided for analysis6 Journal of Transplantation
according to transplant year. Unfortunately, this kind of
power calculation is rarely stated in transplantation reports,
and few studies are prospective with randomization. Aspirin
has been suggested to be a more convincing preventer of
thrombosis [11, 57]. Nevertheless, this should be carefully
administered as it increases the bleeding risk when graft
biopsy is needed at short notice. To overcome this, low
molecular weight heparin can be initiated perioperatively
and used during the time when renal graft biopsy should
be an option. Also administration of rabbit antithymocyte
globulin in a pediatric population decreased the platelet
count and reduced thrombosis risk signiﬁcantly [31]. The
distribution of thrombotic risk factors was similar in the
groups, but it was not a randomized study.
Delayed graft function is strongly correlated to thrombo-
sis and a vascular cause for decreased graft function should
always be considered [6, 14, 21]. Neither the degree of
H L Am i s m a t c h[ 5, 13, 25] nor immunosuppression with
cyclosporine [5, 6, 26, 27] was correlated to thrombotic
events.
5. GraftSalvage IsPossible
Diagnosis of vascular thrombosis can be time consuming,
from request to implementation, and may thus be delayed.
Consequently, kidney grafts developing thrombosis are most
often lost, and the patient is returned to dialysis treatment.
However, with early diagnosis and intervention, it is possible
to save the kidney [16, 20, 33, 58–60]. Even up to 15–20
hours after onset of symptoms, salvage has been reported
[61, 62]. Flow in the occluded vessel can be reestablished
by open surgery with urgent thrombectomy [16, 33]. If the
thrombosis is a late complication, local thrombolysis by an
endovascular access [58, 59] may be tried; this is, however,
most likely more risky in a recently operated patient with an
increased risk of bleeding.
6. Methods for Diagnosis of
Vascular Complications
Venous thrombosis classically presents itself with a swollen
tender graft and hematuria, while arterial thrombosis can be
more silent with a sudden drop in urine output. Intrarenal
thrombosis may also be involved in severe rejections. Symp-
toms are often sparse, and the risk of delayed graft function
is high. This can be masked by a prior low urine production
or native kidney function in preemptive patients. Usually
thrombotic events occur within the ﬁrst 10 postoperative
days, in 93% of the cases within day seven [5]. Arterial
thrombosis is often presented later than venous thrombosis
[14], but the latter can also occur as a late complication.
When vascular thrombosis is suspected clinically or in
a routine screening, the diagnosis is conﬁrmed by color
Doppler ﬂow examinations, which may also be used within
the ﬁrst hours after transplantation if the kidney is not
functioning at once after revascularization. This technique
detects vascular complications in general, including renal
artery stenosis, with an overall sensitivity and speciﬁcity of
88% and 85%, respectively [63]. The accuracy of complete
vascular thrombosis detection is higher but, nevertheless,
false-positive as well as false-negative results can still be seen
[64], and the diagnosis is often made too late to salvage
the transplanted kidney, also due to delay from request
to realization of the procedure. It is a static method that
most often has to be repeated in patients with delayed graft
function [65], because it is impossible to perform both
ultrasound and biopsies at intervals frequent enough for
safe early warnings, and these patients are at a higher risk
of thrombosis, as mentioned above. When the thrombosed
kidneyisremoved,itshouldbehistopathologicallyexamined
toexcluderejectionastheprimaryevent[21].Duringsalvage
surgery, a renal biopsy is often requested.
7. Reducing EarlyRenal GraftLoss
Despite meticulous attentions to the risk factors discussed,
thrombosis is not completely preventable and means to
a fast early detection of this complication are desirable
in order to implement the above-mentioned opportunities
for salvage. Some steps have been taken in this direction,
and thermodiﬀusion has been suggested as a possible new
dynamic diagnostic technique. A small thermodiﬀusion
electrode placed in the tissue continuously measures the
absolute microcirculation in mL/100g tissue per minute. It
has been applied to ischemic porcine kidneys [66]a n dl i v e r s
[67]. Furthermore, it has been clinically applied to thirty
renal transplant grafts [68]. All studies found a signiﬁcantly
lower microcirculation in the organs subjected to most
ischemic damage, but this technique still needs further
validation, and there have been no new publications on the
subject since 2004.
Microdialysis is another minimally invasive technique
for dynamic monitoring of the local metabolism, which
is being increasingly used experimentally as well as in the
clinic. A small catheter is placed in the tissue of interest and
by simple diﬀusion through a semipermeable membrane;
the concentration of local metabolites can be estimated.
The reconstructive surgeons have used it for more than
ten years for free ﬂap monitoring, for example, when
the esophagus is reconstructed by a free jejunal ﬂap after
carcinoma resection. Critical ischemia locally within the ﬂap
is detected by microdialysis; accordingly, the ﬂap can be
reoperated and revascularized in time [69]. The two-lumen
catheter is continuously perfused and samples are taken
every 30 or 60 minutes for analysis with results provided
within minutes. The free ﬂap is monitored for 4–7 days
after surgery; this timeframe is also relevant following renal
transplantation, where 93% of thromboses occur within the
ﬁrst 7 days [5]. Up till February 2012, more than 14,000
studies on microdialysis have been published; of these 183
have been made on kidneys including recent publications on
renal ischemia. In pigs, microdialysis detects renal ischemia
within 10–30 minutes, while metabolites remain at stable
levels when no ischemia is present. This has been closely
studied in diﬀerent animal models of total ischemia [70–72],
partial ischemia [73], autotransplantation with subsequentJournal of Transplantation 7
postoperative ischemia [74], or transplantation with risk of
thrombosis [75]. All studies had equal conclusions, with
a fast detection of renal ischemia by use of microdialysis.
The ﬁrst investigations on human kidneys undergoing
nephrectomy due to cancer [76] have recently been carried
out. They found similar results, indicating that a clinical
application of the technique seems feasible.
8. Conclusions
Arterial and venous renal graft thromboses are rare, but
nevertheless devastating complications that usually lead to
graft loss and accounts for a considerable fraction of early
graft losses. Especially in the situation with delayed graft
function, there is a need for continuous monitoring to
facilitate salvage and avoid explorative surgery when no
thrombosis is present.
The most signiﬁcant risk factors for thrombosis are
donor-age below 6 or above 60 years or recipient-age below
5–6 years, per- or postoperatively hemodynamic instability,
PD, diabetic nephropathy, a history of thrombosis, deceased
donor, or more than 24 hours CIT. Multiple arteries and
right kidney are not as severe risk factors as earlier thought,
but should, nevertheless, be handled very carefully by the
surgeon. A lot of the risk factors are not adjustable, and the
kidneysaretobeusedasthereisuniversalorganshortageand
a need for kidneys even from marginal donors. When risk
factors are present, the number of thrombotic events may
be reduced, for example, by aggressive ﬂuid management
of pediatric patients or anticoagulation of thrombophilic
patients. Furthermore, there is a need for early detection as
thrombosis is not completely preventable. Microdialysis may
be suitable for this.
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